Rezolute, Inc. (NASDAQ:RZLT - Get Free Report) Director Wladimir Hogenhuis bought 10,000 shares of Rezolute stock in a transaction on Tuesday, February 18th. The shares were purchased at an average cost of $4.70 per share, with a total value of $47,000.00. Following the acquisition, the director now directly owns 77,267 shares of the company's stock, valued at approximately $363,154.90. The trade was a 14.87 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Rezolute Stock Up 1.8 %
Rezolute stock traded up $0.08 during midday trading on Thursday, reaching $4.63. The company's stock had a trading volume of 337,775 shares, compared to its average volume of 529,148. Rezolute, Inc. has a fifty-two week low of $1.45 and a fifty-two week high of $6.19. The company has a market cap of $280.28 million, a P/E ratio of -3.80 and a beta of 1.10. The business has a 50-day simple moving average of $4.84 and a 200-day simple moving average of $4.90.
Rezolute (NASDAQ:RZLT - Get Free Report) last posted its earnings results on Wednesday, February 12th. The company reported ($0.22) EPS for the quarter, topping analysts' consensus estimates of ($0.33) by $0.11. As a group, equities analysts forecast that Rezolute, Inc. will post -0.93 earnings per share for the current year.
Institutional Trading of Rezolute
A number of hedge funds and other institutional investors have recently made changes to their positions in RZLT. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Rezolute during the third quarter worth about $65,000. Jacobs Levy Equity Management Inc. acquired a new stake in shares of Rezolute during the third quarter worth about $239,000. State Street Corp increased its position in shares of Rezolute by 11.6% during the third quarter. State Street Corp now owns 125,472 shares of the company's stock worth $609,000 after purchasing an additional 13,000 shares in the last quarter. XTX Topco Ltd increased its position in shares of Rezolute by 67.4% during the third quarter. XTX Topco Ltd now owns 56,375 shares of the company's stock worth $273,000 after purchasing an additional 22,704 shares in the last quarter. Finally, MML Investors Services LLC acquired a new stake in shares of Rezolute during the third quarter worth about $57,000. Institutional investors and hedge funds own 82.97% of the company's stock.
Analysts Set New Price Targets
RZLT has been the subject of a number of research analyst reports. Guggenheim reissued a "buy" rating on shares of Rezolute in a report on Monday, February 10th. Wedbush reaffirmed an "outperform" rating and issued a $112.00 price target on shares of Rezolute in a report on Monday, November 4th. JMP Securities increased their price target on Rezolute from $8.00 to $9.00 and gave the company a "market outperform" rating in a report on Thursday, February 13th. Craig Hallum upgraded Rezolute to a "strong-buy" rating in a research report on Tuesday, February 4th. Finally, HC Wainwright reiterated a "buy" rating and issued a $14.00 price objective on shares of Rezolute in a research report on Thursday, February 13th. Seven investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Rezolute has a consensus rating of "Buy" and an average target price of $24.38.
Read Our Latest Research Report on Rezolute
About Rezolute
(
Get Free Report)
Rezolute, Inc, a clinical stage biopharmaceutical company, develops therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Rezolute, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rezolute wasn't on the list.
While Rezolute currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
